GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Trump Says Anthropic No Longer Seen as National Security Threat 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 
NEW YORK, Jan. 21, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Nobilis Health Corp. (“Nobilis”) (NYSE MKT:HLTH) between April 2, 2015 and January 6, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of Texas on behalf of Nobilis shareholder. If you purchased or otherwise acquired Nobilis securities between April 2, 2015 and January 6, 2016, your rights may be affected by this action. To get more information go to:
http://zlk.9nl.com/nobilis-health
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Nobilis’ financial statements contained numerous errors concerning the classification of warrants and options, business combination accounting, share-based compensation, and other financial and operating results; (2) Nobilis overstated its net income for the year ended December 31, 2014 by more than $4 million; (3) Nobilis overstated its net income for the quarter ended March 31, 2015 by more than $3.27 million; and (4) as a result, defendants’ statements about Nobilis’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
If you suffered a loss in Nobilis you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
